Kate Bechtold | IR |
Liz Barrett | President and CEO |
Mark Schoenberg | CMO |
Peter Pfreundschuh | CFO |
Derek Archila | Stifel |
Ram Selvaraju | H.C. Wainwright |
Boris Peaker | Cowen |
Matt Kaplan | Ladenburg Thalmann |
Chris Howerton | Jefferies |
Good morning, ladies and gentlemen. Thank you for standing by and welcome to UroGen Pharma's First Quarter 2019 Financial Results and Business Update Conference Call. It is now my pleasure to turn the call over to Kate Bechtold, Director of Corporate Communications and Investor Relations for UroGen Pharma. Please go ahead.
Thank you, operator.